Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring that patients can access their innovative latest-generation therapies
Mr Kasvi, you were nominated to head up Janssen’s Lithuanian office back in November 2017. What was the strategic mission assigned to you when taking over the reins of the affiliate?
"Janssen is very eager to sit down with the authorities, payers and healthcare providers to establish an agreed framework where the value of our overall contribution is properly appreciated."
